InvestorsHub Logo
Followers 826
Posts 119465
Boards Moderated 15
Alias Born 09/05/2002

Re: DewDiligence post# 2688

Tuesday, 02/06/2018 4:20:49 PM

Tuesday, February 06, 2018 4:20:49 PM

Post# of 4859
GILD 4Q17 results/2018 guidance:

http://investors.gilead.com/phoenix.zhtml?c=69964&p=irol-newsArticle&ID=2330690

http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9Mzk3OTQ2fENoaWxkSUQ9LTF8VHlwZT0z&t=1&cb=636534633626809804

2018 guidance for all products sales is $20-21B, down from $25.7B in 2017.

2018 guidance for HCV sales is $3.5-4.0B, down from $9.1B in 2017 (see slide #35 at above link).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News